Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,380,226
-$336,771 QoQ
Shares Held
26,755
+0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#683
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Welch & Forbes LLC holds $565,568,902 across 11 Drug Manufacturers - General names. GILD ranks #10 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
172,704 | $207,146,375 | |
| 2 | JNJ |
Johnson & Johnson
|
657,989 | $167,109,466 | |
| 3 | ABBV |
AbbVie Inc.
|
345,978 | $87,061,903 | |
| 4 | MRK |
Merck & Co., Inc.
|
316,952 | $40,728,332 | |
| 5 | GSK |
GSK plc
|
518,597 | $27,184,854 | |
| 6 | AMGN |
Amgen Inc
|
25,959 | $9,400,273 | |
| 7 | NVS |
Novartis AG
|
57,984 | $9,087,252 | |
| 8 | PFE |
Pfizer Inc
|
341,080 | $8,213,206 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,380,226 | 26,755 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $3,716,997 | 26,670 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,286,363 | 26,775 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,988,564 | 26,924 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,985,063 | 26,924 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,072,859 | 27,424 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,502,672 | 27,094 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,278,771 | 27,180 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,867,221 | 27,215 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,036,716 | 27,805 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,367,031 | 29,219 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,315,196 | 30,894 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $2,406,896 | 31,230 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,658,856 | 32,046 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $2,818,455 | 32,830 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,179,939 | 35,337 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $2,202,537 | 35,634 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $2,528,646 | 42,534 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $3,114,823 | 42,898 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,984,201 | 42,723 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $2,917,735 | 42,372 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $2,767,909 | 42,827 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $2,550,331 | 43,775 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $2,818,084 | 44,597 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $3,477,226 | 45,194 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $3,484,563 | 46,610 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||